AI assistant
Twist Bioscience Corp — Director's Dealing 2021
Sep 16, 2021
31873_dirs_2021-09-16_daf365ad-7439-4cf9-8ae9-ed4e3480fd36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-09-13
Reporting Person: Cho Dennis (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-13 | Common Stock | A | 4097 | — | Acquired | 4097 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-13 | Employee Stock Option (right to buy) | $115.93 | A | 8194 | Acquired | 2031-09-12 | Common Stock (8194) | Direct |
Footnotes
F1: Represents a restricted stock unit award ("RSU") of which 25% of the total number of RSUs vest on the first anniversary of September 13, 2021 and 1/16th of the total number of RSUs vest on each quarterly anniversary thereafter, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F2: 25% of the shares subject to the option vest and become exercisable on the one (1) year anniversary of September 13, 2021 and 1/48 of the shares subject to the option vest and become exercisable monthly thereafter, subject to the Reporting Person's continuous service through each vesting date.